V

Vera Zherebtsova

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

3 papers and 209 citations.

3Publications

209Total Citations

Top publicationsby citations

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Vânia Hungria, María-Victoria Mateos, Ana Carolina Ribas de Almeida et al.|New England Journal of Medicine|2024

Cited by 162

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

Elias Jabbour, H. Kantarjian, Vivian G. Oehler et al.|JAMA Oncology|2024

Cited by 26

Results from the randomized phase III DREAMM-7 study of belantamab mafodotin (belamaf) + bortezomib, and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM).

María‐Victoria Mateos, Vânia Hungria, Paweł Robak et al.|Journal of Clinical Oncology|2024

Cited by 21

Indexing the rest of 3 publications…